深度学习与影像组学特征联合肿瘤免疫异质性预测结肠癌微血管侵犯
多中心回顾性研究纳入1007例结肠癌患者,基于增强静脉期CT提取影像组学与深度学习特征构建DLR融合模型预测微血管侵犯,内部验证AUC 0.883、外部验证AUC 0.855,并发现DLRS高低风险组间免疫细胞浸润与免疫检查点表达存在显著差异(P<0.05)。
要点
- DLR融合模型预测结肠癌MVI的内部验证AUC为0.883(95%CI 0.828-0.937)。
- 外部验证队列AUC达0.855(95%CI 0.775-0.935)。
- 基于DLRS分层的TCGA-COAD高低风险组免疫细胞浸润和免疫检查点表达差异显著(P<0.05)。
核心结论
- 基于增强CT的DLR融合模型可有效预测结肠癌MVI状态,作为无创术前评估工具,并揭示DLRS与肿瘤微环境免疫异质性之间的潜在关联,为优化个体化治疗策略提供思路。
研究设计与样本
- 多中心回顾性研究,共纳入来自三个医疗中心和TCGA-COAD数据库的1007例结肠癌患者;医疗中心1和2按7:3分为训练队列(n=592)和内部验证队列(n=255),医疗中心3(n=135)和TCGA-COAD数据库(n=25)作为外部验证队列;从增强静脉期CT图像提取影像组学和深度学习特征,用机器学习算法筛选特征并构建影像组学模型、深度学习模型和DLR融合模型。
诊断标准与关键数值
- DLR融合模型预测MVI的内部验证队列AUC为0.883(95%CI 0.828-0.937),外部验证队列AUC为0.855(95%CI 0.775-0.935),性能优于单独影像组学模型和深度学习模型;模型评价指标包括AUC、敏感度和特异度,原文未报告敏感度和特异度的具体数值。
临床应用与阅片要点
- 作者认为该DLR融合模型可作为无创术前评估工具预测结肠癌MVI,并提示DLRS与肿瘤微环境免疫异质性存在潜在关联。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: This study aims to develop and validate a deep learning radiomics signature (DLRS) that integrates radiomics and deep learning features for the non-invasive prediction of microvascular invasion (MVI) in patients with colon cancer (CC). Furthermore, the study explores the potential association between DLRS and tumor immune heterogeneity.
MATERIALS AND METHODS: This study is a multi-center retrospective study that included a total of 1007 patients with colon cancer (CC) from three medical centers and The Cancer Genome Atlas (TCGA-COAD) database. Patients from Medical Centers 1 and 2 were divided into a training cohort (n = 592) and an internal validation cohort (n = 255) in a 7:3 ratio. Medical Center 3 (n = 135) and the TCGA-COAD database (n = 25) were used as external validation cohorts. Radiomics and deep learning features were extracted from contrast-enhanced venous-phase CT images. Feature selection was performed using machine learning algorithms, and three predictive models were developed: a radiomics model, a deep learning (DL) model, and a combined deep learning radiomics (DLR) model. The predictive performance of each model was evaluated using multiple metrics, including the area under the curve (AUC), sensitivity, and specificity. Additionally, differential gene expression analysis was conducted on RNA-seq data from the TCGA-COAD dataset to explore the association between the DLRS and tumor immune heterogeneity within the tumor microenvironment.
RESULTS: Compared to the standalone radiomics and deep learning models, DLR fusion model demonstrated superior predictive performance. The AUC for the internal validation cohort was 0.883 (95% CI: 0.828-0.937), while the AUC for the external validation cohort reached 0.855 (95% CI: 0.775-0.935). Furthermore, stratifying patients from the TCGA-COAD dataset into high-risk and low-risk groups based on the DLRS revealed significant differences in immune cell infiltration and immune checkpoint expression between the two groups (P < 0.05).
CONCLUSION: The contrast-enhanced CT-based DLR fusion model developed in this study effectively predicts the MVI status in patients with CC. This model serves as a non-invasive preoperative assessment tool and reveals a potential association between the DLRS and immune heterogeneity within the tumor microenvironment, providing insights to optimize individualized treatment strategies.
引用
- Jia J, Wang J, Zhang Y, et al. Deep Learning and Radiomic Signatures Associated with Tumor Immune Heterogeneity Predict Microvascular Invasion in Colon Cancer. Acad Radiol. 2025. PMID: 40413149. doi:10.1016/j.acra.2025.05.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。